ES2363023T3 - Mimeticuerpos de unión a receptor de melanocortina, composiciones, procedimientos y usos. - Google Patents

Mimeticuerpos de unión a receptor de melanocortina, composiciones, procedimientos y usos. Download PDF

Info

Publication number
ES2363023T3
ES2363023T3 ES05819741T ES05819741T ES2363023T3 ES 2363023 T3 ES2363023 T3 ES 2363023T3 ES 05819741 T ES05819741 T ES 05819741T ES 05819741 T ES05819741 T ES 05819741T ES 2363023 T3 ES2363023 T3 ES 2363023T3
Authority
ES
Spain
Prior art keywords
seq
polypeptide
image
alpha
msh
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES05819741T
Other languages
English (en)
Spanish (es)
Inventor
Mark Cunningham
Vedrana Stojanovic-Susulic
Karyn O'neil
Chichi Huang
Jeffrey Luo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Biotech Inc
Original Assignee
Centocor Ortho Biotech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centocor Ortho Biotech Inc filed Critical Centocor Ortho Biotech Inc
Application granted granted Critical
Publication of ES2363023T3 publication Critical patent/ES2363023T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C07K14/68—Melanocyte-stimulating hormone [MSH]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A61K38/1796—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/04—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Emergency Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Cardiology (AREA)
  • Biotechnology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ES05819741T 2004-10-25 2005-10-25 Mimeticuerpos de unión a receptor de melanocortina, composiciones, procedimientos y usos. Expired - Lifetime ES2363023T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US62196004P 2004-10-25 2004-10-25
US621960P 2004-10-25

Publications (1)

Publication Number Publication Date
ES2363023T3 true ES2363023T3 (es) 2011-07-19

Family

ID=36228385

Family Applications (1)

Application Number Title Priority Date Filing Date
ES05819741T Expired - Lifetime ES2363023T3 (es) 2004-10-25 2005-10-25 Mimeticuerpos de unión a receptor de melanocortina, composiciones, procedimientos y usos.

Country Status (28)

Country Link
US (1) US20060105951A1 (enExample)
EP (1) EP1812046B1 (enExample)
JP (1) JP2008517605A (enExample)
KR (1) KR101255140B1 (enExample)
CN (1) CN101437540B (enExample)
AT (1) ATE501731T1 (enExample)
AU (1) AU2005299440B2 (enExample)
BR (1) BRPI0518411A2 (enExample)
CA (1) CA2585287A1 (enExample)
CY (1) CY1111486T1 (enExample)
DE (1) DE602005026970D1 (enExample)
DK (1) DK1812046T3 (enExample)
EA (1) EA200700944A1 (enExample)
EC (1) ECSP077416A (enExample)
ES (1) ES2363023T3 (enExample)
HR (1) HRP20110405T1 (enExample)
IL (1) IL182683A0 (enExample)
MA (1) MA28943B1 (enExample)
ME (1) ME01234B (enExample)
MX (1) MX2007004974A (enExample)
NO (1) NO20072499L (enExample)
PL (1) PL1812046T3 (enExample)
PT (1) PT1812046E (enExample)
RS (1) RS51789B (enExample)
SI (1) SI1812046T1 (enExample)
TN (1) TNSN07157A1 (enExample)
WO (1) WO2006047535A2 (enExample)
ZA (1) ZA200704260B (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7910101B2 (en) * 2004-10-25 2011-03-22 Centocor, Inc. Melanocortin receptor binding mimetibodies, compositions, methods and uses
US7790671B2 (en) * 2005-10-07 2010-09-07 Codman & Shurtleff, Inc. Implantable pump for protein delivery for obesity control by drug infusion into the brain
AU2009257631B2 (en) 2008-06-09 2014-07-24 Palatin Technologies, Inc. Melanocortin receptor-specific peptides for treatment of sexual dysfunction
AR072072A1 (es) * 2008-06-09 2010-08-04 Palatin Technologies Inc Peptidos especificos del receptor de melanocortina para el tratamiento de la obesidad / 669
US8614185B2 (en) * 2009-05-04 2013-12-24 Centocor Ortho Biotech Inc. Fusion proteins of alpha-MSH derivatives and Fc
WO2010144341A2 (en) 2009-06-08 2010-12-16 Palatin Technologies, Inc. Lactam-bridged melanocortin receptor-specific peptides
UY32690A (es) 2009-06-08 2011-01-31 Astrazeneca Ab Péptidos específicos para receptores de melanocortina
CN105037502A (zh) 2009-06-08 2015-11-11 帕拉丁科技公司 黑皮质素受体特异性肽
WO2011063366A1 (en) 2009-11-23 2011-05-26 Palatin Technologies, Inc. Melanocortin-1 receptor-specific cyclic peptides
KR20120102716A (ko) 2009-11-23 2012-09-18 팔라틴 테크놀로지스 인코포레이티드 멜라노코르틴-1 수용체 특이적 선형 펩티드
JP2020141710A (ja) * 2011-07-06 2020-09-10 ゲンマブ エー／エス 抗体重鎖のｃ末端の修飾による補体依存性細胞傷害の調節
CN113272330B (zh) * 2019-03-02 2024-07-26 南通壹宸生物医药科技有限公司 一种双特异抗体

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000033658A1 (en) 1998-12-09 2000-06-15 Eleanor Roosevelt Institute Composition and method for regulation of body weight and associated conditions
AU2001275930B2 (en) * 2000-07-14 2007-05-10 Eisai Inc. Alpha-msh related compounds and methods of use
AU2003256336A1 (en) * 2002-06-28 2004-01-19 Centocor, Inc. Mammalian epo mimetic ch1 deleted mimetibodies, compositions, methods and uses
EP1545608A4 (en) * 2002-06-28 2006-09-13 Centocor Inc CH1-DELETED MAMMED MUICETIC BODIES, COMPOSITIONS, METHODS AND APPLICATIONS
EA011583B1 (ru) * 2004-03-31 2009-04-28 Сентокор, Инк. Миметические антитела glp-1 человека, композиции, способы и применения

Also Published As

Publication number Publication date
IL182683A0 (en) 2007-09-20
ZA200704260B (en) 2009-03-25
TNSN07157A1 (en) 2008-11-21
CY1111486T1 (el) 2015-08-05
KR101255140B1 (ko) 2013-04-22
WO2006047535A2 (en) 2006-05-04
AU2005299440B2 (en) 2011-12-15
MA28943B1 (fr) 2007-10-01
CN101437540A (zh) 2009-05-20
US20060105951A1 (en) 2006-05-18
MX2007004974A (es) 2007-10-17
WO2006047535A3 (en) 2008-09-04
SI1812046T1 (sl) 2011-06-30
DE602005026970D1 (de) 2011-04-28
ME01234B (me) 2013-06-20
KR20070085416A (ko) 2007-08-27
BRPI0518411A2 (pt) 2008-11-18
EA200700944A1 (ru) 2008-04-28
ATE501731T1 (de) 2011-04-15
HRP20110405T1 (hr) 2011-06-30
DK1812046T3 (da) 2011-06-06
AU2005299440A1 (en) 2006-05-04
CN101437540B (zh) 2012-12-19
CA2585287A1 (en) 2006-05-04
EP1812046B1 (en) 2011-03-16
JP2008517605A (ja) 2008-05-29
HK1106445A1 (en) 2008-03-14
ECSP077416A (es) 2007-05-30
RS51789B (sr) 2011-12-31
EP1812046A2 (en) 2007-08-01
PT1812046E (pt) 2011-06-28
EP1812046A4 (en) 2009-11-11
PL1812046T3 (pl) 2011-08-31
NO20072499L (no) 2007-07-16

Similar Documents

Publication Publication Date Title
EP2214690B1 (en) Melanocortin receptor binding mimetibodies, compositions, methods and uses
US20230265143A1 (en) Recombinant human epo-fc-fusion proteins with prolonged half-life and enhanced erythropoietic activity in vivo
US20240254185A1 (en) Interleukin-2 variants and methods of uses thereof
ES2306711T3 (es) Metodo y composicion destinada a la prevencion y al tratamiento de la anemia.
ES2257734T3 (es) Activacion de los receptores de oligomerizacion por medio de los ligandos de receptores fusionados.
ES2298785T3 (es) Proteinas de fusion.
ES2363023T3 (es) Mimeticuerpos de unión a receptor de melanocortina, composiciones, procedimientos y usos.
CN118255902A (zh) TGF-β受体胞外域融合分子及其用途
CN114989289A (zh) 新颖的胰岛素类似物及其用途
JP2008537874A (ja) ｓＲＡＧＥミメティボディ、組成物、方法および使用
ES2655941T3 (es) Proteína de fusión
CN113271972B (zh) 用于替代IVIG的多聚体杂交Fc蛋白
CN102875683A (zh) 长效重组人生长激素的Fc融合蛋白
TW202317607A (zh) 融合蛋白及其應用
JP2022033047A (ja) 血液脳関門を越える送達のための併用療法
EP1792626B1 (en) Treatment of obesity with alpha-MSH mimetibodies
HK1106445B (en) Melanocortin receptor binding mimetibodies, compositions, methods and uses
CA2704446A1 (en) Melanocortin receptor binding mimetibodies, compositions, methods and uses
US20240350588A1 (en) Gdf15 fusion proteins and use thereof
CN111100210B (zh) 一种Fc融合蛋白及其应用
WO2021031736A1 (zh) 多功能抗体、其制备及其用途